- Our Doctors
- Dr Alexandra Flynn
Dr Alexandra Flynn
MBBS (Hons), FRACP, BSc (Adv Maths), Medical Oncologist
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interest in gastrointestinal (GI), prostate, lung, melanoma, breast
Dr Alexandra Flynn studied at the University of Sydney before completing her medical oncology training at the Calvary Mater Newcastle and the Central Coast Cancer Centre.
Dr Flynn developed research expertise as a Clinical Trial Fellow during her PhD. Her research aims to improve survival by individualising chemotherapy dosing. She has received research funding from Tour de Cure, NSWRCRN, AVANT & AGITG. She is the primary investigator for the FFTV clinical trial & is involved in the development of international guidelines (ADDIKD).
Alexandra finds it a privilege to look after patients during what is often the most challenging time of their lives and hopes to bring clear communication and caring to each of her patients.
Professional memberships
- Fellowship of the Royal Australian College of Physicians (RACP)
- Australian Gastrointestinal Trials Group (AGITG)
- American Society of Clinical Oncology (ASCO)
- European Society of Clinical Oncology (ESMO)
- Medical Oncology Group of Australia (MOGA)
Publications
Flynn, A., Galettis, P., Gurney, H., Michael, M., Desar, I., Westerdijk, K., ... & Martin, J. (2024). Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists. Internal Medicine Journal.
Martin, J. H., Galettis, P., Flynn, A., & Schneider, J. (2024). Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors. Pharmacology research & perspectives, 12(2), e1182.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.